~tigenix-9478
Who has the exclusive right to develop and commercialize Cx601 outside the U.S.?
What is the acquisition amount?
What are forward-looking statements?
How many shareholders are there in Japanese Securities Companies?
What is Takeda Pharmaceuticals' vision for gastrointestinal and inflammatory diseases?
Who is acting as the depositary for TiGenix's American Depositary Shares?
What is the purpose of the ADMIRE-CD II study?
What is the period of the tender offer?
What is Cx601?
What medical condition does Cx601 treat?
How many shareholders are there in Japanese Business Corporations?
Will the Company update or revise any forward-looking statements?
What is the indication for Cx601?
Are there any reports available for FY2018?
What is the percentage of shares held by Japanese Securities Companies?
